�������

PROMETEO II from the Italian Space Agency (ASI) is a continuation of an ongoing study aimed to investigate how exposure to microgravity and space radiation affects cellular response to stress, as well as the neuroprotective effects of nanoparticles based on nanoceria. The results could help develop protective countermeasures for future spaceflight missions and build on efforts to develop therapeutic tools to treat neurodegenerative diseases on Earth.